NEW COMPOSITIONS AND METHODS FOR CELL KILLING

• US 20100136143A1
• Filed: 04/03/2008
• Published: 06/03/2010
• Est. Priority Date: 04/03/2007
• Status: Abandoned Application

• Current Assignee: Oplon B.V.
• Original Assignee: Oplon B.V.
• Inventors: Bukshpan, Shmuel
• Application Number:
  US12/594,384
• Publication Number:
  US 20100136143A1
• Time in Patent Office: Days
• US Class Current: 424/724
• CPC Class Codes: A01N 25/34 Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
• CPC Class Codes: A01N 37/08 containing carboxylic groups or thio analogues thereof, directly attached by the carbon atom to a cycloaliphatic ring; Derivatives thereof
• CPC Class Codes: A01N 37/20 containing the group , wherein Cn means a carbon skeleton not containing a ring; Thio analogues thereof
• CPC Class Codes: A01N 41/04 Sulfonic acids; Derivatives thereof
• CPC Class Codes: A01N 61/00 Biocides, pest repellants or attractants, or plant growth regulators containing substances of unknown or undetermined composition, e.g. substances characterised only by the mode of action

Abstract

The present invention discloses an insoluble proton sink or source (PSS), useful for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of the LTC upon contact. The PSS comprises (i) proton source or sink providing a buffering capacity; and (ii) means providing proton conductivity and/or electrical potential. The PSS is effectively disrupting the pH homeostasis and/or electrical balance within the confined volume of the LTC and/or disrupting vital intercellular interactions of the LTCs while efficiently preserving the pH of the LTCs'"'"' environment. The invention also provides articles of manufacture comprises the PSS and presents an effective method for killing the LTCs.

Claims

1. An insoluble proton sink or source (PSS), useful for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of the LTC upon contact;

the PSS comprising (i) proton source or sink providing a buffering capacity; and

(ii) means providing proton conductivity and/or electrical potential;

wherein the PSS is effectively disrupting the pH homeostasis and/or electrical balance within the confined volume of the LTC and/or disrupting vital intercellular interactions of the LTCs while efficiently preserving the pH of the LTCs'"'"' environment.

2. The PSS of claim 1, wherein said proton conductivity is provided by water permeability and/or by wetting, especially wherein said wetting is provided by hydrophilic additives.

3. The PSS of claim 2, wherein said proton conductivity or wetting is provided by inherently proton conductive materials (IPCMs) and/or inherently hydrophilic polymers (IHPs), especially by IPCMs and/or IHPs selected from a group consisting of sulfonated tetrafluoroethylene copolymers;

sulfonated materials selected from a group consisting of silica, polythion-ether sulfone (SPIES), styrene-ethylene-butylene-styrene (S-SEBS), polyether-ether-ketone (PEEK), poly(arylene-ether-sulfone) (PSU), Polyvinylidene Fluoride (PVDF)-grafted styrene, polybenzimidazole (PBI) and polyphosphazene;

proton-exchange membrane made by casting a polystyrene sulfonate (PSSnate) solution with suspended micron-sized particles of cross-linked PSSnate ion exchange resin;

commercially available Nation™ and

derivatives thereof.

4. The PSS of claim 1, comprising two or more, either two-dimensional (2D) or three-dimensional (3D) PSSs, each of which of said PSSs consisting of materials containing highly dissociating cationic and/or anionic groups (HDCAs) spatially organized in a manner which efficiently minimizes the change of the pH of the LTC'"'"'s environment;

each of said HDCAs is optionally spatially organized in specific either 2D, topologically folded 2D surfaces, or 3D manner efficiently which minimizes the change of the pH of the LTC'"'"'s environment;

further optionally, at least a portion of said spatially organized HDCAs are either 2D or 3D positioned in a manner selected from a group consisting of (i) interlacing;

(ii) overlapping;

(iii) conjugating;

(iv) either homogeneously or heterogeneously mixing; and

(iv) tiling the same.

5. The PSS of claim 1, wherein said PSS is effectively disrupting the pH homeostasis within a confined volume while efficiently preserving the entirety of said LTC'"'"'s environment;

and further wherein said environment'"'"'s entirety is characterized by parameters selected from a group consisting of said environment functionality, chemistry;

soluble'"'"'s concentration, possibly other then proton or hydroxyl concentration;

biological related parameters;

ecological related parameters;

physical parameters, especially particles size distribution, rehology and consistency;

safety parameters, especially toxicity, otherwise LD50 or ICT50 affecting parameters;

olphactory or organoleptic parameters (e.g., color, taste, smell, texture, conceptual appearance etc);

or any combination of the same.

6. The PSS of claim 1, useful for disrupting vital intracellular processes and/or intercellular interactions of said LTC, while both (i) effectively preserving the pH of said LTC'"'"'s environment and (ii) minimally affecting the entirety of the LTC'"'"'s environment such that a leaching from said PSS of either ionized or neutral atoms, molecules or particles (AMP) to the LTC'"'"'s environment is minimized.

7. The PSS of claim 1, useful for disrupting vital intracellular processes and/or intercellular interactions of said LTC, while less disrupting pH homeostasis and/or electrical balance within at least one second confined volume (e.g., non-target cells, NTC).

8. The PSS of claim 7, wherein said differentiation between said LTC and NTC is obtained by one or more of the following means (i) providing differential ion capacity;

(ii) providing differential pH values; and

, (iii) optimizing PSS to target cell size ratio;

(iv) providing a differential spatial, either 2D, topologically folded 2D surfaces, or 3D configuration of said PSS;

(v) providing a critical number of PSS′

particles (or applicable surface) with a defined capacity per a given volume; and

(vi) providing size exclusion means.

9. The PSS of claim 1, wherein the PSS is naturally occurring organic acid containing carbocsylic and/or sulfonic acid groups, especially compositions selected from a group consisting of abietic acid (C₂₀H₃₀O₂) provided in colophony/rosin, pine resin, acidic and basic terpenes.

10. The PSS of claim 1, additionally comprising and effective measure of additives.

11. An article of manufacture, comprising at least one insoluble non-leaching PSS according to claim 1;

said PSS, located on the internal and/or external surface of said article, is provided useful, upon contact, for disrupting pH homeostasis and/or electrical balance within at least a portion of an LTC while effectively preserving pH &

functionality of said surface.

12. The article of manufacture of claim 11 is provided useful, upon contact for cell killing, having at least one external proton-permeable surface with a given functionality, said surface is at least partially composed of, or topically and/or underneath layered with a PSS, such disruption of vital intracellular processes and/or intercellular interactions of said LTC is provided, while said LTC'"'"'s environment'"'"'s pH &

said functionality is effectively preserved.

13. The article of manufacture of claim 11, comprising a surface Methods, and one or more external proton-permeable layers, each of which of said layers is disposed on at least a portion of said surface;

wherein said layer is at least partially composed of or layered with a PSS such that vital intracellular processes and/or intercellular interactions of said LTC are disrupted, while said LTC'"'"'s environment'"'"'s pH &

said functionality is effectively preserved.

14. The article of manufacture of claim 13, comprising (i) at least one PSS;

and (ii) one or more preventive barriers, providing said PSS with a sustained long activity;

preferably wherein at least one barrier is a polymeric preventive barrier adapted to avoid heavy ion diffusion;

further preferably wherein said polymer is an ionomeric barrier, and particularly a commercially available Nafion™

.

15. The PSS of claim 1, adapted to avoid development of LTC'"'"'s resistance and selection over resistant mutations.

25. A method for the production of an article of manufacture, comprising steps of providing an PSS as defined in claim 1;

locating said PSS on top or underneath the surface of said article; and

upon contacting said PSS with a LTC, disrupting the pH homeostasis and/or electrical balance within at least a portion of said LTC while effectively preserving pH &

functionality of said surface.

26. The method of claim 25, further comprising steps of:

a. providing at least one external proton-permeable surface;

b. providing at least a portion of said surface with at least one PSS, and/or layering at least one PSS on top or underneath said surface;

hence killing LTCs or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC, while effectively preserving said LTC'"'"'s environment'"'"'s pH &

functionality.

27. The method of claim 25, further comprising steps of:

a. providing at least one external proton-permeable surface with a given functionality;

b. disposing one or more external proton-permeable layers topically and/or underneath at least a portion of said surface;

said one or more layers are at least partially composed of or layered with at least one PSS; and

,

c. killing LTCs, or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC, while effectively preserving said LTC'"'"'s environment'"'"'s pH &

surface functionality.

30. A method for inducing apoptosis in at least a portion of LTCs population;

said method comprising steps of;

a. obtaining at least one PSS as defined in claim 1;

b. contacting said PSS with an LTC; and

,

c. effectively disrupting the pH homeostasis and/or electrical balance within said LTC such that said LTC'"'"'s apoptosis is obtained, while efficiently preserving the pH of said LTC'"'"'s environment.

31. A method for avoiding development of LTC'"'"'s resistance and selecting over resistant mutations, said method comprising steps of:

a. obtaining at least one PSS as defined in claim 1;

b. contacting said PSS with an LTC; and

,

c. effectively disrupting the pH homeostasis and/or electrical balance within said LTC, such that development of LTC'"'"'s resistance and selecting over resistant mutations is avoided, while efficiently preserving the environment of said LTC'"'"'s.

32. A method of treating a patient, comprising steps of:

a. obtaining a non-naturally occurring medical implant or otherwise medical device;

b. providing said implant with at least one PSS as defined in claim 1, adapted for disrupting pH homeostasis and/or electrical balance within an LTC;

c. implanting said implant within a patient, or applying the same to a surface of said patient such that said implant is contacting at least one LTC; and

,

d. disrupting vital intracellular processes and/or intercellular interactions of said LTC, while effectively preserving the pH of said LTC'"'"'s environment

33. A method of treating a patient, comprising steps of

a. administrating to a patient an effective measure of PSSs as defined in claim 1, in a manner said PSSs contacts at least one LTC;

and,

b. disrupting vital intracellular processes and/or intercellular interactions of said LTC, while effectively preserving the pH of said LTC'"'"'s environment.

34. A method of regenerating a PSS as defined in claim 1;

comprising at least one step selected from a group consisting of (i) regenerating said PSS;

(ii) regenerating its buffering capacity; and

(iii) regenerating its proton conductivity.

16. A method for killing living target cells (LTCs), or otherwise disrupting vital intracellular processes and/or intercellular interactions of said LTC;

said method comprising steps of

a. providing at least one PSS having (i) proton source or sink providing a buffering capacity; and

(ii) means providing proton conductivity and/or electrical potential;

b. contacting said LTCs with said PSS; and

,

c. by means of said PSS, effectively disrupting the pH homeostasis and/or electrical balance within said LTC while efficiently preserving the pH of said LTC'"'"'s environment.

17. The method of claim 16, wherein said step (a) further comprising a step of providing said PSS with water permeability and/or wetting characteristics, in particular, wherein said proton conductivity and wetting is at least partially obtained by providing said PSS with hydrophilic additives.

18. The method of claim 16, further comprising a step of providing the PSS with inherently proton conductive materials (IPCMs) and/or inherently hydrophilic polymers (IHPs), especially by selecting said IPCMs and/or IHPs selected from a group consisting of sulfonated tetrafluoroethylene copolymers;

sulfonated materials selected from a group consisting of silica, polythion-ether sulfone (SPTES), styrene-ethylene-butylene-styrene (S-SEBS), polyether-ether-ketone (PEEK), poly(arylene-ether-sulfone) (PSU), Polyvinylidene Fluoride (PVDF)-grafted styrene, polybenzimidazole (PBI) and polyphosphazene;

proton-exchange membrane made by casting a polystyrene sulfonate (PSSnate) solution with suspended micron-sized particles of cross-linked PSSnate ion exchange resin;

commercially available Nafion™ and

derivatives thereof.

19. The method of claim 16, further comprising steps of

c. providing two or more, either two-dimensional (2D) or three-dimensional (3D) PSSs, each of which of said PSSs consisting of materials containing highly dissociating cationic and/or anionic groups (HDCAs);

and,

d. spatially organizing said HDCAs in a manner which minimizes the change of the pH of the LTC'"'"'s environment.

20. The method of claim 19, further comprising a step of spatially organizing each of said HDCAs in a specific, either 2D or 3D manner, such that the change of the pH of the LTC'"'"'s environment is minimized.

21. The method of claim 20, wherein said step of organizing is provided by a manner selected from a group consisting of (i) interlacing said HDCAs;

(ii) overlapping said HDCAs;

(iii) conjugating said HDCAs; and

(iv) either homogeneously or heterogeneously mixing said HDCAs; and

(v) tiling the same.

22. The method of claim 16, further comprising a step of disrupting pH homeostasis and/or electrical potential within at least a portion of an LTC by a PSS, while both (i) effectively preserving the pH of said LTC'"'"'s environment;

and (ii) minimally affecting the entirety of said LTC'"'"'s environment;

said method is especially provided by minimizing the leaching of either ionized or electrically neutral atoms, molecules or particles (AMP) from the PSS to said environment.

23. The method of claim 16, further comprising steps of preferentially disrupting pH homeostasis and/or electrical balance within at least one first confined volume (e.g., target living cells, LTC), while less disrupting pH homeostasis within at least one second confined volume (e.g., non-target cells, NTC).

24. The differentiating method of claim 23, wherein said differentiation between said LTC and NTC is obtained by one or more of the following steps:

(i) providing differential ion capacity;

(ii) providing differential pH value;

(iii) optimizing the PSS to LTC size ratio; and

, (iv) designing a differential spatial configuration of said PSS boundaries on top of the PSS bulk;

(v) providing a critical number of PSS′

particles (or applicable surface) with a defined capacity per a given volume; and

(vi) providing size exclusion means.

28. The method of claim 16, comprising steps

a. providing at least one PSS;

and,

b. providing said PSS with at least one preventive barrier such that a sustained long acting is obtained.

29. The method of claim 28, wherein said step of providing said barrier is obtained by utilizing a polymeric preventive barrier adapted to avoid heavy ion diffusion;

preferably by providing said polymer as an ionomeric barrier; and

particularly by utilizing a commercially available Nafion™

product.